PL230364A1 - - Google Patents

Info

Publication number
PL230364A1
PL230364A1 PL23036481A PL23036481A PL230364A1 PL 230364 A1 PL230364 A1 PL 230364A1 PL 23036481 A PL23036481 A PL 23036481A PL 23036481 A PL23036481 A PL 23036481A PL 230364 A1 PL230364 A1 PL 230364A1
Authority
PL
Poland
Application number
PL23036481A
Other versions
PL132428B1 (en
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PL230364A1 publication Critical patent/PL230364A1/xx
Publication of PL132428B1 publication Critical patent/PL132428B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL1981230364A 1980-03-28 1981-03-27 Proces for preparing novel derivatives of 3-/1-piperidinalkyl/-nh-pyrido-/1,2-a/-pyrimidin-4-one PL132428B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13484580A 1980-03-28 1980-03-28

Publications (2)

Publication Number Publication Date
PL230364A1 true PL230364A1 (cs) 1982-03-29
PL132428B1 PL132428B1 (en) 1985-03-30

Family

ID=22465278

Family Applications (2)

Application Number Title Priority Date Filing Date
PL1981230364A PL132428B1 (en) 1980-03-28 1981-03-27 Proces for preparing novel derivatives of 3-/1-piperidinalkyl/-nh-pyrido-/1,2-a/-pyrimidin-4-one
PL1981233902A PL131162B1 (en) 1980-03-28 1981-03-27 Process for preparing novel derivatives of 4h-pyrido /1,2-a/ pyrimidin-4-one

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL1981233902A PL131162B1 (en) 1980-03-28 1981-03-27 Process for preparing novel derivatives of 4h-pyrido /1,2-a/ pyrimidin-4-one

Country Status (5)

Country Link
JP (1) JPS56150091A (cs)
KR (2) KR850000412B1 (cs)
PL (2) PL132428B1 (cs)
SU (1) SU1093251A3 (cs)
ZA (1) ZA812085B (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0615529B2 (ja) * 1985-04-01 1994-03-02 エーザイ株式会社 新規ピペリジン誘導体
ES2087072T3 (es) * 1988-03-28 1996-07-16 Janssen Pharmaceutica Nv Agentes para conservar o restablecer la salud de la piel.
EP3106166B1 (en) 2008-02-29 2020-12-02 VM Therapeutics LLC Compounds for treating pain syndrome and other disorders
CN119528903A (zh) 2012-02-10 2025-02-28 Ptc医疗公司 用于治疗脊髓性肌萎缩的化合物
WO2016196386A1 (en) 2015-05-30 2016-12-08 Ptc Therapeutics, Inc. Methods for modulating rna splicing
CN108697709A (zh) 2015-12-10 2018-10-23 Ptc医疗公司 用于治疗亨廷顿病的方法
WO2018098446A1 (en) 2016-11-28 2018-05-31 Ptc Therapeutics, Inc Methods for modulating rna splicing
US11407753B2 (en) 2017-06-05 2022-08-09 Ptc Therapeutics, Inc. Compounds for treating Huntington's disease
CA3065547A1 (en) 2017-06-14 2018-12-20 Ptc Therapeutics, Inc. Methods for modifying rna splicing
US11382918B2 (en) 2017-06-28 2022-07-12 Ptc Therapeutics, Inc. Methods for treating Huntington's Disease
CA3067592A1 (en) 2017-06-28 2019-01-03 Ptc Therapeutics, Inc. Methods for treating huntington's disease
MX2020009957A (es) 2018-03-27 2021-01-15 Ptc Therapeutics Inc Compuestos para el tratamiento de enfermedad de hungtinton.
CA3103976A1 (en) 2018-06-27 2020-01-02 Ptc Therapeutics, Inc. Heterocyclic and heteroaryl compounds for treating huntington's disease
US11685746B2 (en) 2018-06-27 2023-06-27 Ptc Therapeutics, Inc. Heteroaryl compounds for treating Huntington's disease
JP7515415B2 (ja) 2018-06-27 2024-07-12 ピーティーシー セラピューティクス, インコーポレイテッド ハンチントン病を処置するためのヘテロアリール化合物

Also Published As

Publication number Publication date
PL132428B1 (en) 1985-03-30
SU1093251A3 (ru) 1984-05-15
KR850000412B1 (ko) 1985-03-26
JPS56150091A (en) 1981-11-20
PL233902A1 (cs) 1982-07-19
PL131162B1 (en) 1984-10-31
JPH0215550B2 (cs) 1990-04-12
KR850000413B1 (ko) 1985-03-26
KR830005220A (ko) 1983-08-03
ZA812085B (en) 1982-11-24

Similar Documents

Publication Publication Date Title
FR2473621B1 (cs)
FR2473466B1 (cs)
CH663511GA3 (cs)
DE3153260A1 (cs)
DE3153168A1 (cs)
FR2486512B1 (cs)
DE3153460A1 (cs)
FR2473394B1 (cs)
FR2473149B1 (cs)
CH654544B (cs)
DE3152509T1 (cs)
FR2473805B1 (cs)
FR2473428B1 (cs)
DE3153680A1 (cs)
FR2473445B1 (cs)
FR2473777B3 (cs)
CH655411B (cs)
FR2473388B1 (cs)
FR2475255B1 (cs)
CH655460B (cs)
FR2473556B1 (cs)
FR2492784B1 (cs)
FR2486942B1 (cs)
CH655658B (cs)
FR2473183B1 (cs)